Css LLC Heron Therapeutics, Inc. Transaction History

Css LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.66 - $5.37 $55,860 - $112,770	-21,000 Reduced 70.0%	9,000 $38,000
Q2 2021 Aug 16, 2021	SELL	$13.27 - $18.48 $110,711 - $154,178	-8,343 Reduced 21.76%	30,000 $466,000
Q1 2021 May 17, 2021	BUY	$14.49 - $20.72 $555,590 - $794,466	38,343 New	38,343 $622,000
Q3 2020 Nov 16, 2020	SELL	$13.67 - $17.77 $109,360 - $142,160	-8,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$10.89 - $21.47 $87,120 - $171,760	8,000 New	8,000 $118,000

179

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $188M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.